title: Desipramine in the treatment of adolescents with attention deficit disorder.
abstract: Twelve adolescents with attention deficit disorder were treated with desipramine in an open trial to assess its efficacy and safety. Eleven patients improved within 1 month, and improvement was sustained for 6-12 months without significant adverse effects in nine patients.
mesh_terms: D000293:Adolescent; D000553:Ambulatory Care; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D002986:Clinical Trials as Topic; D003891:Desipramine / Q000009:adverse effects / Q000627:therapeutic use*; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D012894:Sleep Stages
chemical_list: D003891:Desipramine